Gardner Lewis Asset Management »

Intra Cellular Therapies shares owned by Gardner Lewis Asset Management

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by Gardner Lewis Asset Management from 13F filings

Historical chart of Gardner Lewis Asset Management investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by Gardner Lewis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by Gardner Lewis Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $19M 146k 131.92

More positions owned by Gardner Lewis Asset Management

NVIDIA Corporation (NVDA)
Invesco QQQ Oct 17 2025 Option Put Option
Verona Pharma Plc ads (VRNA)
Veritex Hldgs (VBTX)
MasterCard Incorporated (MA)
Ubs Group (UBS)
Boeing Company (BA)
Microsoft Corporation (MSFT)
Interpublic Group of Companies (IPG)
Apple (AAPL)
Amazon (AMZN)
Citigroup (C)
Alphabet Inc Class C cs (GOOG)
Facebook Inc cl a (META)
Kellogg Company (K)

View all positions for Gardner Lewis Asset Management

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies